Consistent with our findings, METTL3 [25], WTAP [6], ZCCHC4 [26], YTHDF2 [5], LRPPRC [27], IGF2BP1 [28], IGF2BP2 [29], and FTO [30] have been reported as potential prognostic indicators involved in diverse pathophysiological processes in HCC. This evidence concerns the gene IGF2BP2 and hepatocellular carcinoma.